Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing NaN - NaN of 30
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Placebo)

Completed
  • Renal Cell Carcinoma
  • Scottsdale, Arizona
  • +185 more
Jan 30, 2023

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib, Nivolumab, Ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • La Jolla, California
  • +159 more
Jan 23, 2023

Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Ipilimumab)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Nivolumab
  • Ipilimumab
  • Saint Louis, Missouri
  • +11 more
Dec 15, 2022

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Study of Kidney Tumors in Younger Patients

Recruiting
  • Adult Cystic Nephroma
  • +24 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +247 more
Sep 2, 2022

Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Stanford, California
  • +182 more
Jul 1, 2022

Melanoma, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (Combination of NKTR-214 + nivolumab)

Completed
  • Melanoma
  • +6 more
  • Combination of NKTR-214 + nivolumab
  • La Jolla, California
  • +57 more
Jun 22, 2022

Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +12 more
  • Nashville, Tennessee
  • +4 more
Feb 3, 2022

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Renal Cell Carcinoma, Clear-cell Metastatic Renal Cell Carcinoma Trial in Canada, United States (Nivolumab, Pazopanib,

Completed
Has Results
  • Renal Cell Carcinoma
  • Clear-cell Metastatic Renal Cell Carcinoma
  • Nivolumab
  • +3 more
  • Duarte, California
  • +13 more
Nov 30, 2021

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab, Bevacizumab, RO6874281)

Completed
  • Renal Cell Carcinoma
  • New Haven, Connecticut
  • +22 more
Sep 10, 2021

Renal Cell Carcinoma Trial in Worldwide (Cabozantinib tablets, Everolimus (Afinitor) tablets)

Completed
Has Results
  • Renal Cell Carcinoma
  • Cabozantinib tablets
  • Everolimus (Afinitor) tablets
  • Birmingham, Alabama
  • +204 more
Apr 1, 2021

Renal Cell Carcinoma Trial in Hamilton, Toronto (SBRT)

Active, not recruiting
  • Renal Cell Carcinoma
  • SBRT
  • Hamilton, Ontario, Canada
  • +1 more
Dec 15, 2020

Non Small Cell Lung Cancer, Renal Cell Carcinoma Trial in Toronto (Durvalumab, Oleclumab)

Withdrawn
  • Non Small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Durvalumab
  • Oleclumab
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 13, 2020

Renal Cell Carcinoma Trial in Canada, United States (Tivozanib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Mobile, Alabama
  • +24 more
Oct 5, 2020

Renal Cell Carcinoma Trial in Worldwide (everolimus, sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Birmingham, Alabama
  • +83 more
Oct 4, 2016

Renal Cell Carcinoma Trial in Worldwide (Bevacizumab, Temsirolimus, Interferon-Alfa 9MU)

Completed
Has Results
  • Renal Cell Carcinoma
  • Little Rock, Arkansas
  • +171 more
Mar 25, 2016

Renal Cell Carcinoma Trial in Toronto (Definity)

Completed
  • Renal Cell Carcinoma
  • Toronto, Ontario, Canada
    Toronto General Hospital
Mar 7, 2016

Renal Cell Carcinoma Trial in Toronto (CellAegis' autoRIC™ Device)

Terminated
  • Renal Cell Carcinoma
  • CellAegis' autoRIC™ Device
  • Toronto, Ontario, Canada
    University Health Network
Dec 9, 2015

Renal Cell Carcinoma, Metastatic Disease Trial in Toronto (Sorafenib)

Completed
  • Renal Cell Carcinoma
  • Metastatic Disease
  • Toronto, Ontario, Canada
    Princess Margaret Hospital, University Health Network
Dec 7, 2015

Renal Cell Carcinoma Trial in Toronto (Sunitinib Malate (Sutent))

Terminated
  • Renal Cell Carcinoma
  • Sunitinib Malate (Sutent)
  • Toronto, Ontario, Canada
    University Health Network, Princess Margaret Hospital
Dec 7, 2015

Renal Cell Carcinoma Trial in Toronto (Sorafenib, external beam radiotherapy)

Completed
  • Renal Cell Carcinoma
  • Toronto, Ontario, Canada
    Princess Margaret Hosptial
Jul 22, 2015

Partial Nephrectomy, Renal Cell Carcinoma Trial in Toronto (Hypoperfusion of renal artery)

Terminated
  • Partial Nephrectomy
  • Renal Cell Carcinoma
  • Hypoperfusion of renal artery
  • Toronto, Ontario, Canada
    University Health Network
Feb 10, 2015

Renal Cell Carcinoma Trial in Worldwide (Sorafenib, temsirolimus (Torisel))

Completed
Has Results
  • Renal Cell Carcinoma
  • Duarte, California
  • +127 more
Oct 28, 2013